Table I.
Demographic characteristics of the intent-to-treat (ITT) study population.
| Prolutex (n = 400) | Endometrin (n = 400) | |
|---|---|---|
| Mean age in years (SD) | 34.3 (4.4) | 34.3 (4.5) |
| Race/ethnicity | ||
| African American | 2.5 | 3.5 |
| Asian | 21.5 | 20.3 |
| Caucasian | 67.3 | 66.3 |
| Hispanic | 8.5 | 8.5 |
| Other | 0.3 | 1.5 |
| Infertility diagnosis | ||
| Male factor | 49.0 | 50.8 |
| Tubal disease | 22.5 | 22.5 |
| Diminished ovarian reserve | 20.0 | 19.8 |
| Unexplained | 14.3 | 16.5 |
| Endometriosis | 11.0 | 7.8 |
| Polycystic ovarian syndrome | 10.5 | 8.3 |
| Anovulatory/ovarian dysfunction | 12.0 | 11.3 |
| Other | 3.8 | 4.5 |
| Duration of infertility in months (SD) | 35.8 (31.1) | 36.2 (27.1) |
| Nulliparity | 47.5 | 50.3 |
| Number prior miscarriages | ||
| 0 | 78.0 | 74.3 |
| 1 | 17.5 | 20.5 |
| 2 | 4.5 | 5.0 |
| Number prior completed IVF cycles | ||
| 0 | 80.0 | 82.3 |
| 1 | 16.3 | 13.8 |
| 2 | 3.8 | 3.5 |
| Body mass index (kg/m2) | ||
| Mean (SD) | 23.5 (3.1) | 23.7 (3.0) |
| Min–Max | 16.6–30.2 | 18.2–30.6 |
| Smoker | 2.0 | 2.3 |
| Baseline FSH in IU/l, mean (SD) | 7.1 (2.2) | 7.0 (2.2) |
| Min–Max | 0.2–14.5 | 1.3–14.9 |
Values are expressed as percentages unless otherwise noted.